A study comparing a drug causing labor pains when given orally vs vaginally in pregnant wome
- Conditions
- Health Condition 1: O80- Encounter for full-term uncomplicated delivery
- Registration Number
- CTRI/2021/01/030348
- Lead Sponsor
- DRRPGMC Kangra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.fetal malpresentations
2.rupture of membranes/ pre-existing chorioamnionitis
3.previous uterine surgery( CS/ hysterotomy/ myomectomy/metroplasty)
4.multifetal gestation
5.antepartum bleeding
6.intrauterine fetal demise
7.Anencephaly
8.allergy to latex.
9.All contraindications to vaginal delivery (eg carcinoma cervix, structural pelvic abnormalities eg rachitic pelvis, Cephalopelvic disproportion.)
10.A previous attempted IOL during current pregnancy.
11.Placenta or vasa previa or cord presentation.
12.Active genital herpes.
13.Contraindications to prostaglandins (eg. Asthma, acute PID, hypersensitivity)
14.Any co-morbid surgical illness (eg. Pyelonephritis, etc)
15.Non reassuring fetal heart rate status.
1.fetal malpresentations
2.rupture of membranes/ pre-existing chorioamnionitis
3.previous uterine surgery( CS/ hysterotomy/ myomectomy/metroplasty)
4.multifetal gestation
5.antepartum bleeding
6.intrauterine fetal demise
7.Anencephaly
8.allergy to latex.
9.All contraindications to vaginal delivery (eg carcinoma cervix, structural pelvic abnormalities eg rachitic pelvis, Cephalopelvic disproportion.)
10.A previous attempted IOL during current pregnancy.
11.Placenta or vasa previa or cord presentation.
12.Active genital herpes.
13.Contraindications to prostaglandins (eg. Asthma, acute PID, hypersensitivity)
14.Any co-morbid surgical illness (eg. Pyelonephritis, etc)
15.Non reassuring fetal heart rate status.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method